Comment on “Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study”

American Journal of Transplantation 2026

View at publisher

Authors: Stefan Reuter, Nils Lachmann, Miha Arnol

DOI: 10.1016/j.ajt.2026.06.003

Cited by: 1

References: 5

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Renal Diseases and Glomerulopathies Psoriasis: Treatment and Pathogenesis

References 5